#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus associated lymphoproliferative disorder Peritoneal mesothelioma malignant Systemic scleroderma Hereditary hypophosphataemic rickets Rosai-Dorfman syndrome Hypophosphatasia Glomerulonephritis acute Glomerulonephritis Uveal melanoma Giant cell tumour of tendon sheath Inborn error of metabolism Pancreatic carcinoma Pyruvate kinase deficiency anaemia Dedifferentiated liposarcoma Rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Life with Disease Medulloblastoma recurrent – Diagnostics Biotinidase deficiency – Basic Information Haemophilia A with anti factor VIII – Diagnostics Chronic granulomatous disease – Trials in Disease Combined immunodeficiency – Life with Disease Brain stem glioma – Treatment Paraneoplastic neurological syndrome – Life with Disease Factor VIII deficiency – Diagnostics Toxic epidermal necrolysis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VERT-002 Afamelanotide Gallium (68Ga) Gozetotide Ads-011 Mva-Hbvac Minocycline Hydrochloride SPY002 Bempikibart HUMAN PLASMA Abbv-668 BMS-986365 Zanubrutinib Cimetidine PAPAVERINE HYDROCHLORIDE Lenacapavir Sodium Iohexol Methylphenidate Hydrochloride Cefuroxime Sodium Ep0042 Azithromycin Dihydrate More therapies…

    Learn about Your Condition

    Post cardiac arrest syndrome Dry eye Type IIa hyperlipidaemia Complex regional pain syndrome Pathogen resistance Neuroendocrine carcinoma Myotonic dystrophy Coma Thrombocytosis Bipolar I disorder Left ventricular dysfunction Mitochondrial myopathy Adenosquamous cell lung cancer Breast cancer Mucopolysaccharidosis I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Durvalumab, Oleclumab, and Chemotherapy in Patients with Luminal B Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Oleclumab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Belgium France

  • Study of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Fulvestrant
    • Olaparib
    • Durvalumab
    Belgium France Spain

  • Study on the Effects of Inaxaplin for Adults and Children with APOL1-mediated Proteinuric Kidney Disease

    Not recruiting

    4 1
    Investigated Drugs:
    • Inaxaplin
    Belgium France

  • Study of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tucidinostat
    • Nivolumab
    Belgium Czechia France Germany Italy Spain

  • Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Crisantaspase
    • Daunorubicin Hydrochloride
    • Hydrocortisone Sodium Succinate
    Austria Belgium Czechia Denmark Finland France +6

  • Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Monkeypox
    Investigated Drugs:
    • Tecovirimat
    Belgium France Ireland Italy The Netherlands Norway +2

  • Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Czechia France Greece +8
Previous Page
1 … 64 65 66 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!